Triptorelin is primarily used in the treatment of advanced prostate cancer. It works by reducing the production of testosterone, which can slow the growth of prostate cancer cells. Additionally, it is employed in the management of certain hormone-responsive conditions such as endometriosis and uterine fibroids in women. In pediatric endocrinology, it is utilized to treat central precocious puberty by delaying early sexual development. The compound is administered via injection and requires careful monitoring to manage potential side effects and ensure therapeutic efficacy.